Cargando…
Phenotype Standardization for Statin-Induced Myotoxicity
Statins are widely used lipid-lowering drugs that are effective in reducing cardiovascular disease risk. Although they are generally well tolerated, they can cause muscle toxicity, which can lead to severe rhabdomyolysis. Research in this area has been hampered to some extent by the lack of standard...
Autores principales: | Alfirevic, A, Neely, D, Armitage, J, Chinoy, H, Cooper, R G, Laaksonen, R, Carr, D F, Bloch, K M, Fahy, J, Hanson, A, Yue, Q-Y, Wadelius, M, Maitland-van Der Zee, A H, Voora, D, Psaty, B M, Palmer, C N A, Pirmohamed, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172546/ https://www.ncbi.nlm.nih.gov/pubmed/24897241 http://dx.doi.org/10.1038/clpt.2014.121 |
Ejemplares similares
-
Pharmacogenetics of Statin-Induced Myotoxicity
por: Kee, Ping Siu, et al.
Publicado: (2020) -
Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components
por: Turner, Richard Myles, et al.
Publicado: (2019) -
The role of acid-base imbalance in statin-induced myotoxicity
por: Taha, Dhiaa A., et al.
Publicado: (2016) -
Phenotyping Adverse Drug Reactions: Statin-Related Myotoxicity
por: Wiley, Laura K., et al.
Publicado: (2015) -
A common missense variant of LILRB5 is associated with statin intolerance and myalgia
por: K Siddiqui, Moneeza, et al.
Publicado: (2017)